Stephen S. Yoder
2017
In 2017, Stephen S. Yoder earned a total compensation of $1.3M as Chief Executive Officer at Pieris Pharmaceuticals, a 15% increase compared to previous year.
Compensation breakdown
| Bonus | $225,000 |
|---|---|
| Option Awards | $564,201 |
| Salary | $450,000 |
| Other | $10,800 |
| Total | $1,250,001 |
Yoder received $564.2K in option awards, accounting for 45% of the total pay in 2017.
Yoder also received $225K in bonus, $450K in salary and $10.8K in other compensation.
Rankings
In 2017, Stephen S. Yoder's compensation ranked 7,907th out of 14,666 executives tracked by ExecPay. In other words, Yoder earned more than 46.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,907 out of 14,666 | 46th |
Division Services | 1,441 out of 2,428 | 41st |
Major group Engineering, Accounting, Research, Management, And Related Services | 102 out of 185 | 45th |
Industry group Research, Development, And Testing Services | 31 out of 55 | 44th |
Industry Commercial Physical and Biological Research | 29 out of 50 | 42nd |
Source: SEC filing on June 14, 2018.
Yoder's colleagues
We found three more compensation records of executives who worked with Stephen S. Yoder at Pieris Pharmaceuticals in 2017.